International journal of stroke : official journal of the International Stroke Society
-
Comparative Study Controlled Clinical Trial
N-terminal probrain natriuretic peptide as a biomarker of cardioembolic stroke.
and purpose N-terminal probrain natriuretic peptide, which is mainly produced by the heart, is increased in acute stroke. We aimed to determine if N-terminal probrain natriuretic peptide could be a biomarker for ischemic stroke with a cardioembolic cause. ⋯ N-terminal probrain natriuretic peptide is a biomarker with a good accuracy to predict ischemic stroke of cardioembolic cause, namely associated with atrial fibrillation.